| RS2470160593 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2470165070 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Von Hippel-Lindau syndrome |
| RS2470165203 |
VHL
|
Health Risk |
Pathogenic |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS2470165240 |
VHL
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2470165274 |
VHL
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2470165396 |
VHL
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2470165746 |
ITPR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 15/16, Spinocerebellar ataxia type 15/16 |
| RS2470165771 |
ITPR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2470170430 |
ATP2B2
|
Health Risk |
Pathogenic |
— |
| RS2470170621 |
VHL
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2470170739 |
VHL
|
Health Risk |
Pathogenic |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS2470170764 |
VHL
|
Health Risk |
Pathogenic |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS2470170948 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS2470170952 |
VHL
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2470171093 |
MBD5
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS2470171129 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Von Hippel-Lindau syndrome |
| RS2470171278 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Chuvash polycythemia |
| RS2470171303 |
VHL
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Chuvash polycythemia |
| RS2470171346 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Von Hippel-Lindau syndrome |
| RS2470171381 |
VHL
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2470174791 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2470175213 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS2470175931 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2470179437 |
TMEM43
|
Health Risk |
Likely pathogenic |
Emery-Dreifuss muscular dystrophy 7, autosomal dominant |
| RS2470181227 |
ITPR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gillespie syndrome, Gillespie syndrome |
| RS2470186445 |
GRM7
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with seizures, hypotonia |
| RS2470189052 |
SLC6A1
|
Health Risk |
Likely pathogenic |
— |
| RS2470191807 |
SLC6A1
|
Health Risk |
Pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2470191935 |
SLC6A1
|
Health Risk |
Pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2470192158 |
SLC6A1
|
Health Risk |
Pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2470192319 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2470192385 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2470193069 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2470194710 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2470194778 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2470196296 |
SLC6A1
|
Health Risk |
Pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2470201771 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470201816 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470201839 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470202191 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470202207 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2470202787 |
TTN
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS2470202904 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2470203267 |
SLC6A1
|
Health Risk |
Pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2470203335 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2470203450 |
SLC6A1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2470203986 |
SLC6A1
|
Health Risk |
Pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2470210229 |
SLC6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2470210780 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2470210792 |
SLC6A1
|
Health Risk |
Pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2470210847 |
SLC6A1
|
Health Risk |
Likely pathogenic |
SLC6A1-related disorder, SLC6A1-related disorder |
| RS2470212537 |
ATP2B2
|
Health Risk |
Likely pathogenic |
— |
| RS2470219549 |
XPC
|
Health Risk |
Likely pathogenic |
Xeroderma pigmentosum, group C |
| RS2470219605 |
XPC
|
Health Risk |
Pathogenic |
— |
| RS2470222374 |
XPC
|
Health Risk |
Likely pathogenic |
— |
| RS2470222392 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2470222524 |
XPC
|
Health Risk |
Pathogenic |
— |
| RS2470222589 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2470222613 |
XPC
|
Health Risk |
Pathogenic |
— |
| RS2470222670 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2470222783 |
XPC
|
Health Risk |
Likely pathogenic |
Xeroderma pigmentosum, group C |
| RS2470222791 |
XPC
|
Health Risk |
Likely pathogenic |
— |
| RS2470222842 |
XPC
|
Health Risk |
Likely pathogenic |
Xeroderma pigmentosum, group C |
| RS2470222942 |
XPC
|
Health Risk |
Likely pathogenic |
Xeroderma pigmentosum, group C |
| RS2470223501 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470223574 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470223633 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470223719 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470224446 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2470224452 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2470224623 |
SLC6A1
|
Health Risk |
Pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2470225112 |
XPC
|
Health Risk |
Likely pathogenic |
— |
| RS2470225400 |
XPC
|
Health Risk |
Pathogenic |
— |
| RS2470225440 |
XPC
|
Health Risk |
Pathogenic |
— |
| RS2470225927 |
XPC
|
Health Risk |
Likely pathogenic |
Xeroderma pigmentosum, group C |
| RS2470226337 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470226358 |
CYP27A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470226391 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470226435 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470226496 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470226536 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470226647 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470226691 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470226845 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470226900 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470226909 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470226967 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470227119 |
XPC
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, group C |
| RS2470227142 |
XPC
|
Health Risk |
Pathogenic |
— |
| RS2470227355 |
XPC
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, group C |
| RS2470227377 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470227436 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470227581 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470227583 |
XPC
|
Health Risk |
Likely pathogenic |
Xeroderma pigmentosum, group C |
| RS2470227625 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2470227698 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470228303 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS2470228964 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470228996 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2470229009 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |